Clinical trial
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating…
NCT00052455 · Institute of Cancer Research, United Kingdom, Other · Completed
Key facts
| NCT number | NCT00052455 |
|---|---|
| Title | Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma |
| Official title | A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV |
| Lead sponsor | Institute of Cancer Research, United Kingdom, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | lomustine, procarbazine hydrochloride, temozolomide, vincristine sulfate |
| Enrollment | 500 |
| Start date | Oct 1, 2002 |
| Completion | Sep 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 18, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: